DNA methylation, the most common epigenetic modification, plays a role in tumor cells; promoter hypermethylation of the GSTP1 gene is detected in prostate cancer, and this alteration is strictly limited to malignant cells, including prostate cancer and prostatic intraepithelial neoplasia [15]. This evidence concerns the gene GSTP1 and prostate carcinoma.